Our company's roots in Europe extend back to the 1980s, when both Daiichi and Sankyo established offices in Düsseldorf, Germany. In 1990 Sankyo acquired the Luitpold Werke in Munich, Germany, a mid-sized German pharmaceutical company with production facilities in Pfaffenhofen, Bavaria and Altkirch, France.
In 2006 the merger between the two traditional Japanese enterprises took place in Europe. Today our European headquarters are located in Munich. We currently do business in 13 European countries. Through licensing and sales agreements, our products are available in almost every European market. With about 2,000 employees, we are one of the strongest Japanese pharmaceutical companies located in Europe.
Europe is the third most important market for the Daiichi Sankyo Group following Japan and the United States. Through our French affiliate we also provide pharmaceuticals to patients in many North or West African countries such as Algeria, Burkina Faso, Camerun, Congo, Morocco, Niger, Senegal and Togo.